{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:05:49Z","timestamp":1793736349105,"version":"4.6.1"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Synovitis and gradual joint degeneration are hallmarks of rheumatoid arthritis (RA), a chronic inflammatory illness. To sustain inflammation and tissue damage, pathogenic immune and stromal cells undergo specific metabolic reprogramming that alters glycolysis, oxidative phosphorylation, and lipid metabolism. This pathology is driven by immunometabolic dysregulation, according to new research. This review summarizes the current understanding of cell-type-specific immunometabolic dysregulation in RA, with particular attention to T cells, macrophages, B cells, and fibroblast-like synoviocytes. We assess how high-dimensional biomarkers, such as blood-based metabolomic, transcriptomic, and proteomic signatures, and synovial molecular pathotypes can be used to stratify patients and predict how well biologic and targeted treatments will work. We also reviewed treatment approaches targeting immunometabolic pathways, including new metabolic inhibitors and drug repurposing, such as metformin. To facilitate a more individualized and efficient RA treatment, we conclude by offering a clinically applicable paradigm to integrate immunometabolic profiling into precision medicine.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1691946","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:42:26Z","timestamp":1772779346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunometabolism in rheumatoid arthritis: mechanisms, biomarkers, and the path to precision medicine"],"prefix":"10.3389","volume":"17","author":[{"given":"Xinyu","family":"Liu","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lou","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaomu","family":"Tang","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Fang","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Hu","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.124.323660","article-title":"Intersection of immunology and metabolism in myocardial disease","volume":"134","author":"Thorp","year":"2024","journal-title":"Circ Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"131860","DOI":"10.1016\/j.foodchem.2021.131860","article-title":"Immunometabolism modulation, a new trick of edible and medicinal plants in cancer treatment","volume":"376","author":"Tan","year":"2022","journal-title":"Food Chem"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2019.03.012","article-title":"Microglia immunometabolism: From metabolic disorders to single cell metabolism","volume":"94","author":"Paolicelli","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1713148","article-title":"Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases","volume":"16","author":"Cui","year":"2025","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/molecules29061298","article-title":"The impact of glycolysis and its inhibitors on the immune response to inflammation and autoimmunity","volume":"29","author":"Paj\u0105k","year":"2024","journal-title":"Molecules"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2015.09.012","article-title":"Metabolic enzymes enjoying new partnerships as RNA-binding proteins","volume":"26","author":"Castello","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.08.009","article-title":"Foundations of immunometabolism and implications for metabolic health and disease","volume":"47","author":"Hotamisligil","year":"2017","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.33091\/amj.2025.159680.2222","article-title":"Biomarkers of sepsis severity: A comparative evaluation of immunological and biochemical parameters","volume":"21","author":"Alshammary","year":"2025","journal-title":"Al-Anbar Med J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"111181","DOI":"10.1016\/j.humimm.2024.111181","article-title":"Correlation of autoimmune response and immune system components in the progression of IgA nephropathy: A comparative study","volume":"85","author":"Al-Karawi","year":"2024","journal-title":"Hum Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100578","DOI":"10.1016\/j.obmed.2024.100578","article-title":"Investigating the multifactorial correlation between obesity and rheumatoid arthritis: a study of immunological and biochemical markers","volume":"53","author":"Kadhim","year":"2025","journal-title":"Obes Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.54","article-title":"Fine tuning of immunometabolism for the treatment of rheumatic diseases","volume":"13","author":"Rhoads","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/00258172241235016","article-title":"Diagnostic errors in rheumatology and medico-legal consequences","volume":"92","author":"Golstein","year":"2024","journal-title":"Medico-Legal J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2016.60216","article-title":"Social implications of rheumatic diseases","volume":"54","author":"K\u0142ak","year":"2016","journal-title":"Reumatologia\/Rheumatology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxab021","article-title":"Metabolites as drivers and targets in rheumatoid arthritis","volume":"208","author":"Hanlon","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.04.034","article-title":"Meta-analysis reveals an association of STAT4 polymorphisms with systemic autoimmune disorders and anti-dsDNA antibody","volume":"74","author":"Zheng","year":"2013","journal-title":"Hum Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13479","article-title":"Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells","volume":"202","author":"Canavan","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2025.04.026","article-title":"Angiogenesis in rheumatoid Arthritis: Pathological characterization, pathogenic mechanisms, and nano-targeted therapeutic strategies","volume":"50","author":"Zhao","year":"2025","journal-title":"Bioactive Materials"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2011.01598.x","article-title":"Glycolysis and rheumatoid arthritis","volume":"14","author":"Chang","year":"2011","journal-title":"Int J rheumatic Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/erm.2025.11","article-title":"Unveiling the therapeutic potential: targeting fibroblast-like synoviocytes in rheumatoid arthritis","volume":"27","author":"Yue","year":"2025","journal-title":"Expert Rev Mol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"152586","DOI":"10.1016\/j.semarthrit.2024.152586","article-title":"Metabolic checkpoints in rheumatoid arthritis","volume":"70","author":"Weyand","year":"2025","journal-title":"Semin Arthritis Rheumatism"},{"key":"B22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13075-025-03647-z","article-title":"The Glycolysis-HIF-1\u03b1 axis induces IL-1\u03b2 of macrophages in rheumatoid arthritis","volume":"27","author":"Jia","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3","year":"2017","journal-title":"Immunologic Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2023.04.034","article-title":"Metabolic signature of healthy lifestyle and risk of rheumatoid arthritis: observational and Mendelian randomization study","volume":"118","author":"Zhang","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/ard-2022-223626","article-title":"L-arginine metabolism inhibits arthritis and inflammatory bone loss","volume":"83","author":"Cao","year":"2024","journal-title":"Ann rheumatic Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1403823","article-title":"Targeting dysregulated intracellular immunometabolism within synovial microenvironment in rheumatoid arthritis with natural products","volume":"15","author":"Hu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101812","DOI":"10.1016\/j.berh.2022.101812","article-title":"Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions","volume":"36","author":"Thomas","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B28","volume-title":"Personalized medicine and machine learning: a roadmap for the future","author":"Sebastiani","year":"2022"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01789-0","article-title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","volume":"28","author":"Rivellese","year":"2022","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1186\/ar4565","volume-title":"Moving towards personalized medicine in rheumatoid arthritis","author":"De Jong","year":"2014"},{"key":"B31","doi-asserted-by":"publisher","first-page":"105364","DOI":"10.1016\/j.jbspin.2022.105364","article-title":"Trained immunity and inflammation in rheumatic diseases","volume":"89","author":"Badii","year":"2022","journal-title":"Joint Bone Spine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.961708","article-title":"Metabolomics in rheumatoid arthritis: Advances and review","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.1038\/s41598-021-86729-7","article-title":"Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics","volume":"11","author":"Maciejewski","year":"2021","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-019-1625-z","article-title":"Metabolomic profile overlap in prototypical autoimmune humoral disease: a comparison of myasthenia gravis and rheumatoid arthritis","volume":"16","author":"Blackmore","year":"2020","journal-title":"Metabolomics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1017650","article-title":"Rheumatoid arthritis and mitochondrial homeostasis: The crossroads of metabolism and immunity","volume":"9","author":"Cui","year":"2022","journal-title":"Front Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213103","article-title":"Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis","volume":"77","author":"Bustamante","year":"2018","journal-title":"Ann rheumatic Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652771","article-title":"Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis","volume":"12","author":"Qiu","year":"2021","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41584-022-00771-x","article-title":"Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications","volume":"18","author":"Fearon","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/ar1447","article-title":"Oxidation in rheumatoid arthritis","volume":"6","author":"Hitchon","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.03.008","article-title":"Role of mitochondrial dysfunction on rheumatic diseases","volume":"165","author":"Vaamonde-Garc\u00eda","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1394108","article-title":"Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1380-0","article-title":"Autophagy enhances mesenchymal stem cell-mediated CD4+ T cell migration and differentiation through CXCL8 and TGF-\u03b21","volume":"10","author":"Cen","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2019-0002","article-title":"Immunometabolism: an overview and therapeutic prospects in autoimmune diseases","volume":"11","author":"Stathopoulou","year":"2019","journal-title":"Immunotherapy"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1610254","article-title":"Immunomodulatory mechanisms of the gut microbiota and metabolites on regulatory T cells in rheumatoid arthritis","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11926-025-01180-1","article-title":"T cell dysregulation in Rheumatoid Arthritis: from genetic susceptibility to established disease","volume":"27","author":"Chin","year":"2025","journal-title":"Curr Rheumatol Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1565133","article-title":"Restoring immune tolerance in pre-RA: immunometabolic dialogue between gut microbiota and regulatory T cells","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2024.2330636","article-title":"Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis","volume":"46","author":"Mondal","year":"2024","journal-title":"Immunopharmacol Immunotoxicology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00571","article-title":"The interplay between monocytes\/macrophages and CD4+ T cell subsets in rheumatoid arthritis","volume":"6","author":"Roberts","year":"2015","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/diseases12050081","article-title":"Target role of monocytes as key cells of innate immunity in rheumatoid arthritis","volume":"12","author":"Salnikova","year":"2024","journal-title":"Diseases"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20150900","article-title":"The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease","volume":"213","author":"Shirai","year":"2016","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03978-5","article-title":"Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types","volume":"78","author":"Umar","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161148","article-title":"The role of dendritic cells and their immunometabolism in rheumatoid arthritis","volume":"14","author":"Suwa","year":"2023","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/art.40793","article-title":"Association of Dendritic cell signatures with autoimmune inflammation revealed by Singleedtio profiling","volume":"71","author":"Ashton","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e202451381","DOI":"10.1002\/eji.202451381","article-title":"Metabolic reprogramming in stromal and immune cells in rheumatoid arthritis and osteoarthritis: therapeutic possibilities","volume":"55","author":"Henry","year":"2025","journal-title":"Eur J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1608675","article-title":"Exploring the differential functions of circulating follicular helper T and peripheral helper T cells in rheumatoid arthritis based on metabolism patterns","volume":"16","author":"Bai","year":"2025","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"R255","DOI":"10.1186\/ar3707","article-title":"A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis","volume":"14","author":"Liu","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0296-7","article-title":"N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation","volume":"20","author":"Wen","year":"2019","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S527687","article-title":"Rheumatoid arthritis therapy based on B cells","volume":"19","author":"Liang","year":"2025","journal-title":"Drug Design Dev Ther"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00338-2","article-title":"Evolution and trajectory of B-cell targeted therapies in rheumatic diseases","volume":"7","author":"Carter","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13075-017-1283-3","article-title":"Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"19","author":"Takahashi","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12838","article-title":"Immunometabolism in the development of rheumatoid arthritis","volume":"294","author":"Weyand","year":"2020","journal-title":"Immunol Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e210032","DOI":"10.20900\/immunometab20210032","article-title":"Immunometabolism: an emerging target for immunotherapies to treat rheumatoid arthritis","volume":"3","author":"Mangal","year":"2021","journal-title":"Immunometabolism"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e95228","DOI":"10.1172\/jci.insight.95228","article-title":"Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis","volume":"3","author":"Canavan","year":"2018","journal-title":"JCI Insight"},{"key":"B65","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in early and late stages of rheumatoid arthritis","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/art.40223","article-title":"Review: metabolic control of immune system activation in rheumatic diseases","volume":"69","author":"Perl","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"10594","DOI":"10.3390\/ijms262110594","article-title":"Rheumatoid arthritis: biomarkers and the latest breakthroughs","volume":"26","author":"Xue","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13317-021-00152-6","article-title":"Potential clinical biomarkers in rheumatoid arthritis with an omic approach","volume":"12","author":"Puentes-Osorio","year":"2021","journal-title":"Autoimmun Highlights"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3390\/ijms23052871","article-title":"Inflammation and bone metabolism in rheumatoid arthritis: molecular mechanisms of joint destruction and pharmacological treatments","volume":"23","author":"Maeda","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.07.023","article-title":"Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis","volume":"85","author":"Giollo","year":"2025","journal-title":"Ann Rheumatic Diseases"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2020.1707671","article-title":"Synovial biopsies in inflammatory arthritis: precision medicine in rheumatoid arthritis","volume":"20","author":"Small","year":"2020","journal-title":"Expert Rev Mol Diagnostics"},{"key":"B72","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar2302","article-title":"Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure","volume":"9","author":"Scir\u00e8","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/jpm15120622","article-title":"Biopsy-driven synovial pathophenotyping in RA: A new approach to personalized treatment","volume":"15","author":"Ketabchi","year":"2025","journal-title":"J Personalized Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1038\/s41467-025-60987-9","article-title":"Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis","volume":"16","author":"Lewis","year":"2025","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-021-02537-4","article-title":"Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity","volume":"23","author":"Hur","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B77","doi-asserted-by":"publisher","first-page":"108078","DOI":"10.1016\/j.intimp.2021.108078","article-title":"Mechanistic insights into the role of B cells in rheumatoid arthritis","volume":"99","author":"Singh","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1667662","article-title":"Integrative multi-omic profiling in blood reveals distinct immune and metabolic signatures between ACPA-negative and ACPA-positive rheumatoid arthritis","volume":"16","author":"Hur","year":"2025","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2016.02.004","article-title":"Exploration of the serum metabolite signature in patients with rheumatoid arthritis using gas chromatography\u2013mass spectrometry","volume":"127","author":"Zhou","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676105","article-title":"Relationship between inflammation and metabolism in patients with newly presenting rheumatoid arthritis","volume":"12","author":"Jutley","year":"2021","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"122760","DOI":"10.1016\/j.biomaterials.2024.122760","article-title":"Inflammatory stimulus-responsive polymersomes reprogramming glucose metabolism mitigates rheumatoid arthritis","volume":"312","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e000289","DOI":"10.1136\/rmdopen-2016-000289","article-title":"Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis","volume":"2","author":"Sweeney","year":"2016","journal-title":"RMD Open"},{"key":"B83","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/jpm10040271","article-title":"Identification of metabolic biomarkers in relation to methotrexate response in early rheumatoid arthritis","volume":"10","author":"Gosselt","year":"2020","journal-title":"J personalized Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3732-3","article-title":"Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis","volume":"37","author":"Song","year":"2017","journal-title":"Rheumatol Int"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1237","DOI":"10.1002\/cti2.1237","article-title":"Rheumatoid arthritis CD14+ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease","volume":"10","author":"Mcgarry","year":"2021","journal-title":"Clin Trans Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/proteomes13020017","article-title":"Integrative spatial proteomics and single-cell RNA sequencing unveil molecular complexity in rheumatoid arthritis for novel therapeutic targeting","volume":"13","author":"Wang","year":"2025","journal-title":"Proteomes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e60635","DOI":"10.1371\/journal.pone.0060635","article-title":"Development of a multi-biomarker disease activity test for rheumatoid arthritis","volume":"8","author":"Centola","year":"2013","journal-title":"PloS One"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-021-03169-7","article-title":"Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients","volume":"19","author":"Luan","year":"2021","journal-title":"J Trans Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2023.05.008","article-title":"Obesity, adipokines, and chronic and persistent pain in rheumatoid arthritis","volume":"24","author":"Baker","year":"2023","journal-title":"J Pain"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez169","article-title":"Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis","volume":"58","author":"Fortea-Gordo","year":"2019","journal-title":"Rheumatology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2445537","DOI":"10.1080\/08916934.2024.2445537","article-title":"Analysis of circulating immune cells in patients with rheumatoid arthritis and positive for hashimoto thyroiditis antibodies: Immune cells in RA & Hashimoto\u2019s patients","volume":"58","author":"Jun-Jie","year":"2025","journal-title":"Autoimmunity"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2174\/0929867329666220907151213","article-title":"Immunometabolism dysfunction in the pathophysiology and treatment of rheumatoid arthritis","volume":"30","author":"Masoumi","year":"2023","journal-title":"Curr Medicinal Chem"},{"key":"B93","volume-title":"Designing metabolite-based therapies to rewire immunometabolism and treat autoimmune rheumatoid arthritis","author":"Mangal","year":"2022"},{"key":"B94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3904\/kjim.2021.363","article-title":"Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease","volume":"37","author":"Kim","year":"2021","journal-title":"Korean J Internal Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.2174\/1573397114666180717145745","article-title":"Metformin one in a million efficient medicines for rheumatoid arthritis complications: Inflammation, osteoblastogenesis, cardiovascular disease, Malignancies","volume":"15","author":"Rajaei","year":"2019","journal-title":"Curr Rheumatol Rev"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01495-y","article-title":"Metformin as adjuvant therapy in obese knee osteoarthritis patients","volume":"32","author":"Aiad","year":"2024","journal-title":"Inflammopharmacology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s13018-024-05120-0","article-title":"Effects of metformin phonophoresis and exercise therapy on pain, range of motion, and physical function in chronic knee osteoarthritis: randomized clinical trial","volume":"19","author":"Abed","year":"2024","journal-title":"J Orthopaedic Surg Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.3471","article-title":"Metformin for knee osteoarthritis in patients with overweight or obesity: a randomized clinical trial","volume":"333","author":"Pan","year":"2025","journal-title":"JAMA"},{"key":"B99","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12951-025-03159-7","article-title":"Effectively alleviate rheumatoid arthritis via maintaining redox balance, inducing macrophage repolarization and restoring homeostasis of fibroblast-like synoviocytes by metformin-derived carbon dots","volume":"23","author":"Zhang","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.726490","article-title":"Efficacy and safety of metformin use in rheumatoid arthritis: a randomized controlled study","volume":"12","author":"Gharib","year":"2021","journal-title":"Front Pharmacol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"107575","DOI":"10.1016\/j.intimp.2021.107575","article-title":"The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial","volume":"95","author":"Abdallah","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2024.2330645","article-title":"T-cell metabolism in rheumatoid arthritis: focus on mitochondrial and lysosomal dysfunction","volume":"46","author":"Parab","year":"2024","journal-title":"Immunopharmacol Immunotoxicology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779787","article-title":"Glycolysis rate-limiting enzymes: novel potential regulators of rheumatoid arthritis pathogenesis","volume":"12","author":"Zuo","year":"2021","journal-title":"Front Immunol"},{"key":"B104","volume-title":"Novel understanding of CD8+ T-cell regulation in Rheumatoid Arthritis\u2013deciphering the close interplay between inflammation, epigenetics, and metabolism","author":"Kraus","year":"2025"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e00940","DOI":"10.1002\/prp2.940","article-title":"2022.A,A,.n resea induces deglycosylation of proinflammatory cytokine receptors and strongly reduces immunological responses in mouse models of inflammation","volume":"10","author":"Uehara","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.713799","article-title":"2-Deoxy-D-glucose alleviates collagen-induced arthritis of rats and is accompanied by metabolic regulation of the spleen and liver","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Joint Bone Spine"},{"key":"B108","doi-asserted-by":"publisher","first-page":"152909","DOI":"10.1016\/j.tox.2021.152909","article-title":"Molecular toxicity of methotrexate in rheumatoid arthritis treatment: A novel perspective and therapeutic implications","volume":"461","author":"Katturajan","year":"2021","journal-title":"Toxicology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/annrheumdis-2021-eular.433","article-title":"AB0249 safety of baricitinib in Japanese patients with rheumatoid arthritis (RA): The 2020 interim report from all-case post marketing surveillance in clinical practice","volume":"80","author":"Fujii","year":"2021","journal-title":"Ann Rheumatic Dis"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.7326\/M19-3369","article-title":"Adverse effects of low-dose methotrexate: a randomized trial","volume":"172","author":"Solomon","year":"2020","journal-title":"Ann Internal Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310476","article-title":"Tofacitinib versus methotrexate in rheumatoid arthritis","volume":"370","author":"Lee","year":"2014","journal-title":"New Engl J Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.4c00067","article-title":"Unveiling novel drug targets and emerging therapies for rheumatoid arthritis: A comprehensive review","volume":"7","author":"Khokhar","year":"2024","journal-title":"ACS Pharmacol Trans Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.09.014","article-title":"Exploring the role of cathepsin in rheumatoid arthritis","volume":"29","author":"Behl","year":"2022","journal-title":"Saudi J Biol Sci"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e1483","DOI":"10.1002\/wsbm.1483","article-title":"Glucose transporter 1 in rheumatoid arthritis and autoimmunity","volume":"12","author":"Zezina","year":"2020","journal-title":"Wiley Interdiscip Reviews: Syst Biol Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/25785826.2018.1531186","article-title":"Immunometabolism in rheumatoid arthritis","volume":"41","author":"Okano","year":"2018","journal-title":"Immunol Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13075-023-03161-0","article-title":"Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis","volume":"25","author":"Ahmed","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-016-0965-7","article-title":"PGK1, a glucose metabolism enzyme, may play an important role in rheumatoid arthritis","volume":"65","author":"Zhao","year":"2016","journal-title":"Inflammation Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701305","article-title":"and maintenance of collagen-induced arthritis","volume":"200","author":"Panneton","year":"2018","journal-title":"J Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"R132","DOI":"10.1186\/ar2799","article-title":"Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA\/1 mice","volume":"11","author":"Bian","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B121","doi-asserted-by":"publisher","first-page":"119615","DOI":"10.1016\/j.jep.2025.119615","article-title":"Ermiao San attenuating rheumatoid arthritis via PI3K\/AKT\/mTOR signaling activate HIF-1\u03b1 induced glycolysis","volume":"345","author":"Zhang","year":"2025","journal-title":"J Ethnopharmacology"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.chmed.2021.09.005","article-title":"Targeting immunometabolism by active ingredients derived from traditional Chinese medicines for treatment of rheumatoid arthritis","volume":"13","author":"He","year":"2021","journal-title":"Chin Herbal Medicines"},{"key":"B123","doi-asserted-by":"publisher","first-page":"111024","DOI":"10.1016\/j.intimp.2023.111024","article-title":"Berberine ameliorates collagen-induced arthritis in mice by restoring macrophage polarization via AMPK\/mTORC1 pathway switching glycolytic reprogramming","volume":"124","author":"Cheng","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"155255","DOI":"10.1016\/j.phymed.2023.155255","article-title":"Berberine modulates the immunometabolism and differentiation of CD4+ T cells alleviating experimental arthritis by suppression of M1-exo-miR155","volume":"124","author":"Cai","year":"2024","journal-title":"Phytomedicine"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.829677","article-title":"The role of resveratrol on rheumatoid arthritis: From bench to bedside","volume":"13","author":"Sheng","year":"2022","journal-title":"Front Pharmacol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","article-title":"Matrix metalloproteinases, vascular remodeling, and vascular disease","volume":"81","author":"Wang","year":"2018","journal-title":"Adv Pharmacol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized medicine: motivation, challenges, and progress","volume":"109","author":"Goetz","year":"2018","journal-title":"Fertility sterility"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2017.08.002","article-title":"Towards personalized medicine for patients with autoimmune diseases: opportunities and challenges","volume":"190","author":"Tavakolpour","year":"2017","journal-title":"Immunol Lett"},{"key":"B129","doi-asserted-by":"publisher","first-page":"101742","DOI":"10.1016\/j.berh.2022.101742","article-title":"Precision medicine in rheumatoid arthritis","volume":"36","author":"Bhamidipati","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/pharmaceutics14081648","article-title":"-Omic approaches and treatment response in rheumatoid arthritis","volume":"14","author":"Madrid-Paredes","year":"2022","journal-title":"Pharmaceutics"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3464-9","article-title":"The metabolic profile in early rheumatoid arthritis: a high prevalence of metabolic obesity","volume":"37","author":"M\u00fcller","year":"2017","journal-title":"Rheumatol Int"},{"key":"B132","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/metabo11120824","article-title":"Plasma metabolome normalization in rheumatoid arthritis following initiation of methotrexate and the identification of metabolic biomarkers of efficacy","volume":"11","author":"Medcalf","year":"2021","journal-title":"Metabolites"},{"key":"B133","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13020-023-00750-8","article-title":"Integrative network fusion-based multi-omics study for biomarker identification and patient classification of rheumatoid arthritis","volume":"18","author":"Ding","year":"2023","journal-title":"Chin Med"},{"key":"B134","article-title":"The role of immunometabolism in disease","volume-title":"Development engineering conferences center articles database","author":"Ghanouni","year":"2024"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1536020","article-title":"Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases","volume":"16","author":"Lu","year":"2025","journal-title":"Front Immunol"},{"key":"B136","first-page":"227","article-title":"New pharmacological strategies in rheumatic diseases","volume":"9","author":"Schiotis","year":"2016","journal-title":"J Med Life"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.02.011","article-title":"From rare to more common: The emerging role of omics in improving understanding and treatment of severe inflammatory and hyperinflammatory conditions","volume":"155","author":"Keskitalo","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e789","DOI":"10.1002\/mco2.789","article-title":"Immunometabolism: signaling pathways, homeostasis, and therapeutic targets","volume":"5","author":"Xu","year":"2024","journal-title":"MedComm"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1777625","DOI":"10.1080\/2162402X.2020.1777625","article-title":"Trial watch: IDO inhibitors in cancer therapy","volume":"9","author":"Le Naour","year":"2020","journal-title":"Oncoimmunology"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2023.08.005","article-title":"Computational approaches in rheumatic diseases\u2013Deciphering complex spatio-temporal cell interactions","volume":"21","author":"Hegarty","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/art.39270","article-title":"Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis","volume":"67","author":"Fujii","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S503118","article-title":"Deciphering immunometabolic landscape in rheumatoid arthritis: integrative multiomics, explainable machine learning and experimental validation","volume":"18","author":"Dong","year":"2025","journal-title":"J Inflammation Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1605317113","article-title":"Intratumoral oxygen gradients mediate sarcoma cell invasion","volume":"113","author":"Lewis","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12838","article-title":"Immunometabolism in the development of rheumatoid arthritis","volume":"294","author":"Weyand","year":"2020","journal-title":"Immunol Rev"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161148","article-title":"The role of dendritic cells and their immunometabolism in rheumatoid arthritis","volume":"14","author":"Suwa","year":"2023","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in early and late stages of rheumatoid arthritis","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S398291","article-title":"The involvement of glucose and lipid metabolism alteration in rheumatoid arthritis and its clinical implication","volume":"16","author":"Luo","year":"2023","journal-title":"J Inflammation Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/MS9.0000000000002890","article-title":"Rheumatoid arthritis: a comprehensive overview of genetic markers, emerging therapies, and personalized medicine","volume":"87","author":"Shakeel","year":"2025","journal-title":"Ann Med Surg"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202502880","article-title":"Double crosseVA,.gy hydrogel for intragel,.gy in injection as modality for macrophages metabolic reprogramming and therapy of rheumatoid arthritis","volume":"2502880","author":"Song","year":"2025","journal-title":"Advanced Funct Materials"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221386","article-title":"Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA","volume":"81","author":"Martinsson","year":"2022","journal-title":"Ann Rheumatic Dis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01432-7","article-title":"Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications","volume":"39","author":"Wei","year":"2020","journal-title":"Oncogene"},{"key":"B152","doi-asserted-by":"publisher","first-page":"e509","DOI":"10.1002\/mco2.509","article-title":"Rheumatoid arthritis: pathogenesis and therapeutic advances","volume":"5","author":"Gao","year":"2024","journal-title":"MedComm"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis\u2014immune cell\u2013fibroblast\u2013bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0334","article-title":"Rheumatoid arthritis: the continuum of disease and strategies for prediction, early intervention, and prevention","volume":"51","author":"O\u2019neil","year":"2024","journal-title":"J Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1691946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:42:33Z","timestamp":1772779353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1691946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":154,"alternative-id":["10.3389\/fimmu.2026.1691946"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1691946","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"article-number":"1691946"}}